tiprankstipranks
Psyence Biomedical (PBM)
NASDAQ:PBM
US Market
PBM
Psyence Biomedical
RESEARCH TOOLSreports
Want to see PBM full AI Analyst Report?

Psyence Biomedical (PBM) Income Statement

253 Followers

Psyence Biomedical Income Statement

Last quarter (Q3 2023), Psyence Biomedical's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Psyence Biomedical's net income was C$-24.76M. See Psyence Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -4.27KC$ -240.00C$ 0.00C$ 0.00
Operating Expenses
C$ 3.66MC$ 2.75MC$ 1.29MC$ 334.29K
Depreciation and Amortization
C$ 4.27KC$ 240.00C$ 0.00C$ 1.85M
EBITDA
C$ 1.03MC$ -51.11MC$ -1.29MC$ -334.29K
Operating Income
C$ -3.66MC$ -2.75MC$ -1.29MC$ -334.29K
Other Income/Expenses
C$ 4.67MC$ -48.41MC$ 9.31MC$ 8.56M
Pretax Income
C$ 1.01MC$ -51.16MC$ 8.01MC$ 8.23M
Net Income
C$ 1.01MC$ -51.16MC$ 8.01MC$ 8.23M
Per Share Metrics
Basic EPS
C$ 1.78C$ -7.85C$ -0.64C$ 0.25
Diluted EPS
C$ 1.78C$ -7.85C$ -0.64C$ 0.25
Weighted Average Shares Outstanding
 568.02K 6.52M 32.67M 32.67M
Weighted Average Shares Outstanding (Diluted)
 568.02K 6.52M 32.67M 32.67M
Currency in CAD

Psyence Biomedical Earnings and Revenue History